drugset / Trial / NCT02316301

Optimal Timing of Misoprostol Administration Prior to Office Hysteroscopy

NCT02316301

Phase 2 Completed 120 enrolled Cairo University
RandomizedParallel-groupTriple-blindTreatment

Summary

The aim of this study was to determine whether misoprostol administered 12 hours before office hysteroscopy can relieve pain more effectively compared with misoprostol administered 3 hours before office hysteroscopy.

Timeline

Start
2015-01
Primary completion
2015-12
Completion
2015-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Misoprostol Other / unclassified 400 ug

Indications

No indication recorded.